News + Filings Transactions
|
Li Dean Y
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.7k | $0.00 | $0 | | 04/21/2023 |
| 07/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.6k | $0.00 | $0 | | 07/03/2023 |
| 05/02/2023 | Merck & Co., Inc. | MRK | Grant | Stock Option (Right to Buy) | 77.5k | $117.89 | $9.1M | | 05/02/2023 |
| 04/21/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Gift | Class A Common Stock | 627.7k | $0.00 | $0 | By Dean Y. Li 2021 GRAT | 04/21/2023 |
| 04/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.7k | $0.00 | $0 | | 04/03/2023 |
| 01/23/2023 | Merck & Co., Inc. | MRK | Grant | Common Stock | 3.3k | $109.88 | $359.9k | | 01/23/2023 |
| 01/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.6k | $0.00 | $0 | | 01/03/2023 |
| 10/03/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.1k | $0.00 | $0 | | 10/03/2022 |
| 07/01/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.4k | $0.00 | $0 | | 07/01/2022 |
| 06/14/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 18.1k | $0.00 | $0 | | 06/14/2022 |
| 06/14/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Stock Option (right to buy) | 36.3k | $6.20 | $225k | | 06/14/2022 |
| 05/03/2022 | Merck & Co., Inc. | MRK | Exercise | Common Stock | 773 | $87.65 | $67.8k | | 05/03/2022 |
| 05/03/2022 | Merck & Co., Inc. | MRK | Payment of Exercise | Common Stock | 381 | $87.65 | $33.4k | | 05/03/2022 |
| 05/03/2022 | Merck & Co., Inc. | MRK | Exercise | Restricted Stock Unit | 773 | $0.00 | $0 | | 05/03/2022 |
| 05/03/2022 | Merck & Co., Inc. | MRK | Grant | Stock Option (Right to Buy) | 75.7k | $87.10 | $6.6M | | 05/03/2022 |
| 05/01/2022 | Merck & Co., Inc. | MRK | Exercise | Common Stock | 1.1k | $88.69 | $94.1k | | 05/01/2022 |
| 05/01/2022 | Merck & Co., Inc. | MRK | Payment of Exercise | Common Stock | 523 | $88.69 | $46.4k | | 05/01/2022 |
| 05/01/2022 | Merck & Co., Inc. | MRK | Exercise | Restricted Stock Unit | 1.1k | $0.00 | $0 | | 05/01/2022 |
| 04/01/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.5k | $0.00 | $0 | | 04/01/2022 |
| 01/03/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 659 | $0.00 | $0 | | 01/03/2022 |
| 12/07/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 14.9k | $20.44 | $304.6k | By Dean Y. Li 2021 GRAT | 12/07/2021 |
| 12/07/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 1000 | $21.06 | $21.1k | By Dean Y. Li 2021 GRAT | 12/07/2021 |
| 11/19/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 13.5k | $20.20 | $272.2k | | 11/17/2021 |
| 11/19/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 13.5k | $20.20 | $272.2k | By Dean Y. Li 2021 GRAT | 11/17/2021 |
| 11/17/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 5.6k | $20.04 | $112.7k | By Dean Y. Li 2021 GRAT | 11/17/2021 |
| 11/17/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 5.6k | $20.04 | $112.7k | | 11/17/2021 |
| 10/01/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 543 | $0.00 | $0 | | 10/01/2021 |
| 07/01/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 330 | $0.00 | $0 | | 07/01/2021 |
| 05/03/2021 | Merck & Co., Inc. | MRK | Exercise | Restricted Stock Unit | 750 | $0.00 | $0 | | 05/01/2021 |
| 05/03/2021 | Merck & Co., Inc. | MRK | Exercise | Common Stock | 750 | $74.50 | $55.9k | | 05/01/2021 |
| 05/03/2021 | Merck & Co., Inc. | MRK | Payment of Exercise | Common Stock | 257 | $74.50 | $19.1k | | 05/01/2021 |
| 05/01/2021 | Merck & Co., Inc. | MRK | Exercise | Restricted Stock Unit | 1k | $0.00 | $0 | | 05/01/2021 |
| 05/01/2021 | Merck & Co., Inc. | MRK | Exercise | Common Stock | 1k | $74.50 | $76.7k | | 05/01/2021 |
| 05/01/2021 | Merck & Co., Inc. | MRK | Payment of Exercise | Common Stock | 354 | $74.50 | $26.4k | | 05/01/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Common Stock | 55.4k | $0.00 | $0 | By Dean Li and Ruth Li Revocable Trust | 04/20/2021 |
|
|